Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 4/20 | 0.52 |
| ▸ | OPRD1 | P41143 | 4/20 | 0.52 |
| ▸ | BACE1 | P56817 | 4/20 | 0.49 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.49 |
| ▸ | MME | P08473 | 1/20 | 0.49 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.49 |
| ▸ | KISS1R | Q969F8 | 3/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30974146 | 0.94 | MME (0.54) | OPRM1OPRD1BACE1BACE2MME | |
| SCHEMBL19245623 | 0.94 | OPRM1 (0.51) | OPRM1OPRD1BACE1BACE2OPRK1 | |
| SCHEMBL30124216 | 0.93 | OPRM1 (0.52) | OPRM1OPRD1BACE1BACE2 | |
| SCHEMBL30122958 | 0.93 | KISS1R (0.53) | OPRM1OPRD1BACE1OPRK1KISS1R | |
| SCHEMBL29860442 | 0.91 | OPRD1 (0.59) | OPRM1OPRD1BACE1BACE2OPRK1 | |
| SCHEMBL29386466 | 0.91 | MME (0.53) | OPRM1OPRD1BACE1MMEOPRK1 | |
| SCHEMBL31215110 | 0.90 | OPRM1 (0.56) | OPRM1OPRD1BACE1MMEOPRK1 | |
| SCHEMBL30123065 | 0.90 | MME (0.59) | OPRM1OPRD1MME | |
| SCHEMBL29824150 | 0.90 | KISS1R (0.48) | OPRM1OPRD1BACE1BACE2OPRK1 | |
| SCHEMBL29860229 | 0.90 | MME (0.47) | OPRM1OPRD1BACE1BACE2MME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4724471-A1 | GLP-1/GIP DUAL, GLP-1/GCG DUAL AND GLP-1/GIP/GCG TRIPLE RECEPTOR AGONISTS | Sun Pharmaceutical Industries Limited (IN) | 2026-04-15 | — | — | EP | disclosed |
| WO-2024252366-A1 | GLP-1/GIP DUAL, GLP-1/GCG DUAL AND GLP-1/GIP/GCG TRIPLE RECEPTOR AGONISTS | SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) | 2024-12-12 | — | — | WO | disclosed |
| EP-4291647-A1 | SUBTILISIN VARIANTS AND THEIR USE | Fresenius Kabi iPSUM S.r.l. (IT) | 2023-12-20 | — | — | EP | disclosed |
| WO-2022171667-A1 | SUBTILISIN VARIANTS AND THEIR USE | Fresenius Kabi Ipsum S.R.L. (IT) | 2022-08-18 | — | — | WO | disclosed |